Vasculitis
Home / Vasculitis
Vasculitis
ANCA-associated vasculitis historically required prolonged high-dose steroids. New targeted therapies include:
- Avacopan (Tavneos®) – C5a receptor inhibition
- Rituximab-based regimens for B-cell–mediated disease
These approaches reduce steroid toxicity while maintaining disease control.
Your Financial Contribution Can Help Us Fund Critical Programs & Initiatives
As a Nonprofit organization, we are deeply committed to raising awareness, providing patient support, and advocating for research for individuals living with various disease states.
Quick Links
Rare Diseases
Contact Us
For general questions about our organization, our mission, or how you can get involved, please email us. We endeavor to respond to all inquiries